tm logo

Monitor this mark

View On USPTO

JUXTAPID
Live/Registered
REGISTERED AND RENEWED

on 13 Dec 2024

Last Applicant/ Owned by

AMRYT PHARMACEUTICALS INC.

45 MESPIL ROAD

DUBLIN

4

Serial Number

85980934 filed on 14th Dec 2012

Registration Number

4508190 registered on 01st Apr 2014

in the Principal Register

Correspondent Address

Richard Todd Armstrong, Ph.D.

Richard Todd Armstrong, Ph.D. CLARK + ELBING LLP

BOSTON, MA 02110-1817

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

JUXTAPID

PHARMACEUTICALS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, IN PARTICULAR, HYPERLIPIDEMIA

Classification Information

Class [005]
Pharmaceutical Products

PHARMACEUTICALS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, IN PARTICULAR, HYPERLIPIDEMIA

First Use Date in General

28th Jan 2013

First Use Date in Commerce

28th Jan 2013

Mark Details

Serial Number

No 85980934

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 51445-T03001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
13th Dec 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
13th Dec 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
13th Dec 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
13th Dec 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05th Sep 2024TEAS SECTION 8 & 9 RECEIVED
01st Apr 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
23rd Jun 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02th May 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02th May 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02th May 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.